Montara Therapeutics
SAN FRANCISCO, California · Biotechnology
Montara Therapeutics is a San Francisco–based precision-medicine neuroscience biotech startup. Our team boasts significant experience from successful biotech firms such as Mitokinin, Denali, and Soteria, supported by a world-class Scientific Advisory Board (SAB). We bring a new approach to tackling challenging established targets, along with unique experience in developing enzyme activators and do
Key facts
- Headquarters
- SAN FRANCISCO, California
- Employees
- 21
- Industries
- Biotechnology
- Status
- Private
- Website
- montaratx.com
- Company page
Recent activity at Montara Therapeutics
- : Montara Therapeutics Appoints Dirk Landgraf as Chief Business Officer
- : Montara Therapeutics has received a non-dilutive grant from The Michael J. Fox Foundation to expand R&D efforts. The funding amount was not disclosed.
- : Montara Appoints Jeremy Grunstein as Chief Business Officer
- : Montara Therapeutics
- : Montara Therapeutics Partners with SV Health Investors’ Dementia Discovery Fund and Two Bear Capital to Develop Safer, More Effective Neuroscience Drugs
- : Montara Therapeutics
Montara Therapeutics funding history
| Date | Round | Amount |
|---|---|---|
| Jun 2026 | Grant | Undisclosed |
| Mar 2025 | Venture | $20.0M |
| Jan 2024 | Venture | $8.0M |
Leadership
- Dirk Landgraf, Chief Business Officer
- Jeremy Grunstein, Chief Business Officer
- Nicholas Hertz, President
- Max Lebovitz, Vice President of Business Operations
Verified email and direct lines for Montara Therapeutics’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.
Employee benefit plans
Montara Therapeutics files 1 employee benefit plan with the U.S. Department of Labor, including a retirement plan. The next plan year renews in Dec 2026.
Companies similar to Montara Therapeutics
- CytoDyn · Biotechnology
- ENDRA Life Sciences · Biotechnology
- Moonwalk Biosciences · Biotechnology
- PDS Biotech · Biotechnology
- Nami Surgical · Biotechnology
About Montara Therapeutics: questions and answers
What does Montara Therapeutics do?
Montara Therapeutics is a San Francisco–based precision-medicine neuroscience biotech startup. Our team boasts significant experience from successful biotech firms such as Mitokinin, Denali, and Soteria, supported by a world-class Scientific Advisory Board (SAB). We bring a new approach to tackling challenging established targets, along with unique experience in developing enzyme activators and do
Where is Montara Therapeutics headquartered?
Montara Therapeutics is headquartered in SAN FRANCISCO, California.
How many employees does Montara Therapeutics have?
Montara Therapeutics has about 21 employees.
Has Montara Therapeutics raised funding?
Yes. Fundz has recorded 3 funding events for Montara Therapeutics. The most recent, Grant of Undisclosed, was in Jun 2026.
Who leads Montara Therapeutics?
Nicholas Hertz is a President at Montara Therapeutics.
What is the latest news on Montara Therapeutics?
On Sep 15, 2026, Montara Therapeutics Appoints Dirk Landgraf as Chief Business Officer
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy